| Literature DB >> 34926970 |
Sheng Zheng1,2,3, Uwe Schlink4, Kin-Fai Ho5, Ramesh P Singh6, Andrea Pozzer7.
Abstract
PM2.5 is a major component of air pollution in China and has a serious threat to public health. It is very important to quantify spatial characteristics of the health effects caused by outdoor PM2.5 exposure. This study analyzed the spatial distribution of PM2.5 concentration (45.9 μg/m3 national average in 2016) and premature mortality attributed to PM2.5 in cities at the prefectural level and above in China in 2016. Using the Global Exposure Mortality Model (GEMM), the total premature mortality in China was estimated to be 1.55 million persons, and the per capita mortality was 11.2 per 10,000 persons in the year 2016, resulting in higher estimates compared to the integrated exposure-response model. We assessed the premature mortality attributed to PM2.5 through common diseases, including ischemic heart disease (IHD), cerebrovascular disease (CEV), chronic obstructive pulmonary disease (COPD), lung cancer (LC), and lower respiratory infections (LRI). The premature mortality due to IHD and CEV accounted for 68.5% of the total mortality, and the per capita mortality (per 10,000 persons) for all ages due to IHD was 3.86, the highest among diseases. For the spatial distribution of disease-specific premature mortality, the top two highest absolute numbers of premature mortality associated with IHD, CEV, LC, and LRI, respectively, were found in Chongqing and Beijing. In 338 cities of China, we have found a significant positive spatial autocorrelation of per capita premature mortality, indicating the necessity of coordinated regional governance for an efficient control of PM2.5.Entities:
Keywords: China; PM2.5; premature mortality; spatial distribution
Year: 2021 PMID: 34926970 PMCID: PMC8647684 DOI: 10.1029/2021GH000532
Source DB: PubMed Journal: Geohealth ISSN: 2471-1403
Figure 1Spatial distribution of ground PM2.5 monitoring sites and population in 2016, (a) refers to the PM2.5 monitoring sites, (b) refers to the population in cities at the prefectural level and above in China.
GEMM Parameter Estimates for the Population Above 25 years by Cause of Death (Burnett et al., 2018)
| Cause of death |
| Standard error |
|
|
|
|---|---|---|---|---|---|
| IHD | 0.2969 | 0.01787 | 1.9 | 12 | 40.2 |
| CEV | 0.2720 | 0.07697 | 6.2 | 16.7 | 23.7 |
| COPD | 0.2510 | 0.06762 | 6.5 | 2.5 | 32 |
| LC | 0.2942 | 0.06147 | 6.2 | 9.3 | 29.8 |
| LRI | 0.4468 | 0.11735 | 6.4 | 5.7 | 8.4 |
Figure 2Boxplot (median and interquartile range) of monthly PM2.5 concentrations in China in the year 2016. The black line represents the mean of monthly PM2.5 concentrations.
Figure 3Spatial distribution of the annual PM2.5 concentration across China in 2016.
Earlier Estimations of Premature Mortality Due to PM2.5 by the IER Model in China
| Studies | Year | Disease‐specific premature mortality |
|---|---|---|
| Lelieveld et al. ( | 2010 | 1,357,000 persons due to CEV, COPD, IHD, LC, and acute LRI |
| Xie et al. ( | 2010 | 1,255,400 persons due to CEV, COPD, IHD, and LC |
| Hu et al. ( | 2013 | 1,300,000 persons due to CEV, COPD, IHD, and LC |
| J. Liu et al. ( | 2013 | 1,367,300 persons due to CEV, COPD, IHD, and LC |
| Maji et al. ( | 2016 | 964,000 persons due to CEV, COPD, IHD, and LC |
The Ten Cites With the Highest Number of Total Premature Mortality
| City | PM2.5 concentration (μg/m3) | Premature mortality | Uncertainty ranges of the premature mortality (95% CI) | Population (10,000 persons) | Per capita mortality for all ages (per 10,000 persons) | |
|---|---|---|---|---|---|---|
| Lower bound | Upper bound | |||||
| Chongqing | 53.0 | 36,593 | 23,234 | 46,980 | 3048.43 | 12 |
| Beijing | 72.0 | 26,945 | 19,357 | 32,508 | 2172.9 | 12.4 |
| Chengdu | 61.9 | 21,231 | 13,344 | 27,144 | 1591.76 | 13.34 |
| Tianjin | 70.1 | 20,040 | 14,470 | 24,127 | 1562.12 | 12.83 |
| Baoding | 92.3 | 19,260 | 13,519 | 23,264 | 1163.45 | 16.55 |
| Shijiazhuang | 95.0 | 18,023 | 12,667 | 21,738 | 1078.46 | 16.71 |
| Harbin | 50.3 | 16,583 | 11,777 | 20,391 | 1066.5 | 15.55 |
| Shanghai | 45.6 | 16,153 | 10,418 | 20,762 | 2419.7 | 6.68 |
| Linyi | 67.5 | 15,278 | 10,628 | 18,751 | 1044.3 | 14.63 |
| Handan | 81.5 | 15,024 | 10,484 | 18,267 | 949.28 | 15.83 |
The Premature Mortality Attributed to PM2.5 by Disease Category and the Corresponding Per Capita Mortality (IHD, CEV, COPD, and LC for People >25 years and LRI for People >25 years and Infants <5 years) in China in the Year 2016
| Disease | Premature mortality (million) | Percent (%) | Per capita mortality for all ages (per 10,000 persons) | Uncertainty ranges of the premature mortality (95% CI, million) | |
|---|---|---|---|---|---|
| Lower bound | Upper bound | ||||
| IHD | 0.534 | 34.5 | 3.86 | 0.489 | 0.575 |
| CEV | 0.525 | 34 | 3.8 | 0.266 | 0.724 |
| COPD | 0.242 | 15.6 | 1.75 | 0.127 | 0.333 |
| LC | 0.142 | 9.2 | 1.03 | 0.093 | 0.182 |
| LRI | 0.103 | 6.7 | 0.75 | 0.062 | 0.13 |
Figure 4Spatial distribution of the premature mortality associated with (a) IHD, (b) CEV, (c) COPD, (d) LC, (e) LRI across China in the year 2016.
The Top Five Cities With the Highest Per Capita Mortality (Per 10,000 Persons) Due to Each Disease
| IHD | CEV | COPD | LC | LRI | |||||
|---|---|---|---|---|---|---|---|---|---|
| City | Per capita mortality | City | Per capita mortality | City | Per capita mortality | City | Per capita mortality | City | Per capita mortality |
| Kashi | 8.21 | Shijiazhuang | 7.04 | Zigong | 4.24 | Jinzhou | 1.77 | Naqu | 1.87 |
| Hetian | 7.6 | Baoding | 6.97 | Luzhou | 3.98 | Liaocheng | 1.75 | Zunyi | 1.76 |
| Aksu | 7.21 | Hengshui | 6.83 | Chengdu | 3.89 | Shenyang | 1.74 | Liupanshui | 1.70 |
| Harbin | 7.04 | Xingtai | 6.82 | Meishan | 3.78 | Anshan | 1.73 | Guiyang | 1.63 |
| Urumqi | 6.82 | Handan | 6.64 | Kashi | 3.73 | Dezhou | 1.73 | Qiandongnan | 1.54 |
Figure 5Moran's I scatter plot of the per capita premature mortality in 338 cities.
Figure 6The local spatial autocorrelation of the per capita premature mortality due to PM2.5 in China in 2016, (a) the local indicator spatial autocorrelation (LISA) cluster map, and (b) LISA significance map.